Senisca is a biotech spinout company that creates a new generation of oligonucleotide-based interventions.
Senisca has raised $4.7M in total funding. The most recent round was Seed. The last funding was announced in March 2024.
Senisca's investors include R42 Group, Innovate UK, Longevitytech.fund, Lifespan Vision Ventures, APEX Ventures.
Senisca is headquartered in Exeter, United Kingdom.
Senisca is a biotech spinout company that creates a new generation of oligonucleotide-based interventions.
Senisca is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Senisca — Funding & Investors." VCBacked, March 18, 2024, https://www.vcbacked.co/company/senisca. Accessed October 11, 2026.
VCBacked. (2024). Senisca — Funding & Investors. Retrieved October 11, 2026, from https://www.vcbacked.co/company/senisca
{{cite web |title=Senisca — Funding & Investors |url=https://www.vcbacked.co/company/senisca |website=VCBacked |access-date=October 11, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated